Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine-Assisted Psychotherapy Viability in Treating Cancer-Related Emotional Distress

NCT05344625 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT05344625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine-Assisted Psychotherapy Viability in Treating Cancer-Related Emotional Distress
Lead sponsor
Northwell Health
Phase
Phase 1
Overall status
Withdrawn
Start date
October 31, 2023
Completion date
March 15, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, cancer-related problem/condition, depressive symptoms